Efficacy of an integrative approach for bipolar disorder: preliminary results from a randomized controlled trial.
Bipolar disorder
functional remediation
integrative approach
mindfulness
psychoeducation
psychological treatment
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
16 Apr 2021
16 Apr 2021
Historique:
entrez:
16
4
2021
pubmed:
17
4
2021
medline:
17
4
2021
Statut:
aheadofprint
Résumé
Bipolar disorder (BD) represents one of the most therapeutically complex psychiatric disorders. The development of a feasible comprehensive psychological approach to complement pharmacotherapy to improve its clinical management is required. The main objective of the present randomized controlled trial (RCT) was to test the efficacy of a novel adjunctive treatment entitled integrative approach in patients with BD, including: psychoeducation, mindfulness training, and functional remediation. This is a parallel two-armed, rater-blind RCT of an integrative approach plus treatment as usual (TAU), v. TAU alone. Participants were recruited at the Hospital Clinic of Barcelona and randomized to one of the two conditions. They were assessed at baseline and after finishing the intervention. The main outcome variable included changes in psychosocial functioning assessed through the Functioning Assessment Short Test (FAST). After finishing the treatment, the repeated-measures analyses revealed a significant group × time interaction in favor of the patients who received the integrative approach (n = 28) compared to the TAU group (n = 37) (Pillai's trace = 0.10; F(1,57) = 6.9; p = 0.01), improving the functional outcome. Significant effects were also found in two out of the six domains of the FAST, including the cognitive domain (Pillai's trace = 0.25; F(1,57) = 19.1; p < 0.001) and leisure time (Pillai's trace = 0.11; F(1,57) = 7.15; p = 0.01). Regarding the secondary outcomes, a significant group × time interaction in Hamilton Depression Rating Scale changes was detected (Pillai's trace = 0.08; F(1,62) = 5.6; p = 0.02). This preliminary study suggests that the integrative approach represents a promising cost-effective therapy to improve psychosocial functioning and residual depressive symptoms in patients suffering from BD.
Sections du résumé
BACKGROUND
BACKGROUND
Bipolar disorder (BD) represents one of the most therapeutically complex psychiatric disorders. The development of a feasible comprehensive psychological approach to complement pharmacotherapy to improve its clinical management is required. The main objective of the present randomized controlled trial (RCT) was to test the efficacy of a novel adjunctive treatment entitled integrative approach in patients with BD, including: psychoeducation, mindfulness training, and functional remediation.
METHODS
METHODS
This is a parallel two-armed, rater-blind RCT of an integrative approach plus treatment as usual (TAU), v. TAU alone. Participants were recruited at the Hospital Clinic of Barcelona and randomized to one of the two conditions. They were assessed at baseline and after finishing the intervention. The main outcome variable included changes in psychosocial functioning assessed through the Functioning Assessment Short Test (FAST).
RESULTS
RESULTS
After finishing the treatment, the repeated-measures analyses revealed a significant group × time interaction in favor of the patients who received the integrative approach (n = 28) compared to the TAU group (n = 37) (Pillai's trace = 0.10; F(1,57) = 6.9; p = 0.01), improving the functional outcome. Significant effects were also found in two out of the six domains of the FAST, including the cognitive domain (Pillai's trace = 0.25; F(1,57) = 19.1; p < 0.001) and leisure time (Pillai's trace = 0.11; F(1,57) = 7.15; p = 0.01). Regarding the secondary outcomes, a significant group × time interaction in Hamilton Depression Rating Scale changes was detected (Pillai's trace = 0.08; F(1,62) = 5.6; p = 0.02).
CONCLUSION
CONCLUSIONS
This preliminary study suggests that the integrative approach represents a promising cost-effective therapy to improve psychosocial functioning and residual depressive symptoms in patients suffering from BD.
Identifiants
pubmed: 33858527
doi: 10.1017/S0033291721001057
pii: S0033291721001057
pmc: PMC9811269
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-12Références
Behav Modif. 2011 Mar;35(2):111-61
pubmed: 21324944
Int J Neuropsychopharmacol. 2013 Sep;16(8):1719-32
pubmed: 23663490
Bipolar Disord. 2010 Nov;12(7):727-40
pubmed: 21040290
Int J Neuropsychopharmacol. 2019 Aug 1;22(8):467-477
pubmed: 31093646
Bipolar Disord. 2017 Dec 22;:
pubmed: 29271072
J Nerv Ment Dis. 2019 Jun;207(6):440-450
pubmed: 31045980
Am J Psychiatry. 2013 Aug;170(8):852-9
pubmed: 23511717
J Affect Disord. 2018 Mar 1;228:153-159
pubmed: 29248821
Bipolar Disord. 2020 Sep;22(6):641-643
pubmed: 32511859
Am J Psychiatry. 2008 Dec;165(12):1559-65
pubmed: 18829872
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Apr - Jun;13(2):105-110
pubmed: 32376131
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Clin Pract Epidemiol Ment Health. 2011;7:112-6
pubmed: 21687565
Med Clin (Barc). 2002 Sep 28;119(10):366-71
pubmed: 12372167
Bipolar Disord. 2018 Mar;20(2):97-170
pubmed: 29536616
J Affect Disord. 2020 Sep 1;274:1113-1121
pubmed: 32663939
N Engl J Med. 2020 Jul 2;383(1):58-66
pubmed: 32609982
Clin Pract Epidemiol Ment Health. 2007 Jun 07;3:5
pubmed: 17555558
Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13
pubmed: 17391354
J Affect Disord. 2014 Mar;156:46-55
pubmed: 24439829
Clin Psychol Psychother. 2018 Jan;25(1):50-58
pubmed: 28857347
Bipolar Disord. 2020 Jun;22(4):411-412
pubmed: 31724258
Clin Psychol Rev. 2016 Feb;43:47-57
pubmed: 26691629
J Affect Disord. 2015 Feb 1;172:291-9
pubmed: 25451428
J Affect Disord. 2013 Sep 25;150(3):1152-7
pubmed: 23790741
Bipolar Disord. 2008 Jun;10(4):511-9
pubmed: 18452447
Rev Med Chil. 2015 Feb;143(2):213-22
pubmed: 25860364
Arch Gen Psychiatry. 2003 Apr;60(4):402-7
pubmed: 12695318
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Jul - Sep;13(3):165-173
pubmed: 32651030
J Consult Clin Psychol. 2011 Oct;79(5):618-28
pubmed: 21767001
J Clin Psychiatry. 2016 Jan;77(1):100-8
pubmed: 26845265
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Harv Rev Psychiatry. 2014 Nov-Dec;22(6):326-30
pubmed: 25377603
J Affect Disord. 2010 Jun;123(1-3):81-6
pubmed: 19853922
Behav Res Ther. 2013 Jul;51(7):338-43
pubmed: 23639299
Am J Psychiatry. 2004 Feb;161(2):262-70
pubmed: 14754775
J Affect Disord. 2008 Aug;109(3):286-99
pubmed: 18289698
Acta Psychiatr Scand. 2016 Dec;134(6):511-521
pubmed: 27644707
Br J Psychiatry. 2009 Mar;194(3):260-5
pubmed: 19252157
J Affect Disord. 2010 Feb;121(1-2):156-60
pubmed: 19505727
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Br J Psychiatry. 2016 Jan;208(1):87-93
pubmed: 26541692
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Psychother Psychosom. 2004 Sep-Oct;73(5):312-9
pubmed: 15292629
J Affect Disord. 2019 Mar 1;246:763-774
pubmed: 30623822
Br J Psychiatry. 2006 Apr;188:313-20
pubmed: 16582056
Eur Psychiatry. 2013 Jan;28(1):21-9
pubmed: 22534552
Nat Rev Dis Primers. 2018 Mar 08;4:18008
pubmed: 29516993
Arch Gen Psychiatry. 2003 Sep;60(9):904-12
pubmed: 12963672
Arch Gen Psychiatry. 2003 Feb;60(2):145-52
pubmed: 12578431
Eur Neuropsychopharmacol. 2011 Mar;21(3):241-7
pubmed: 21146375
Biol Psychiatry. 2000 Sep 15;48(6):582-92
pubmed: 11018229
Psychother Psychosom. 2005;74(5):295-302
pubmed: 16088267
Bipolar Disord. 2020 May;22(3):216-230
pubmed: 31610086
Psychiatry Res. 2020 Aug;290:113116
pubmed: 32480120
J Affect Disord. 2013 Aug 15;150(1):29-36
pubmed: 23497792
Rev Psiquiatr Salud Ment (Engl Ed). 2019 Jan - Mar;12(1):1-8
pubmed: 30416047
J Clin Psychiatry. 2018 Mar/Apr;79(2):
pubmed: 28703949
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1986 Jul-Aug;14(4):339-42
pubmed: 3776734
J Affect Disord. 2008 Apr;107(1-3):275-9
pubmed: 17884176